NCT03522922 is a Phase 1, PHASE2 clinical trial of Dermaroller in Acne Vulgaris, sponsored by Sohag University.

Who is sponsoring NCT03522922?

NCT03522922 is sponsored by Sohag University.

What drugs are being tested in NCT03522922?

Interventions in NCT03522922: Dermaroller, Topical Vitamin C.

What condition does NCT03522922 study?

NCT03522922 studies Acne Vulgaris, Acne Scars.

Is NCT03522922 still recruiting?

NCT03522922 is currently completed. Last updated 14 May 2018.

Last reviewed 2018-05-14 · How we verify

NCT03522922

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring

Completed Phase 1, PHASE2 Last updated 14 May 2018

What this trial tests

Phase 1, PHASE2 trial testing Dermaroller in Acne Vulgaris in 30 participants. Completed in 31 March 2018.

Timeline

1 June 2016

Primary endpoint
1 February 2018

31 March 2018

Quick facts

Lead sponsor	Sohag University
Phase	Phase 1, PHASE2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 June 2016
Primary completion	1 February 2018
Estimated completion	31 March 2018
Sites	1 location across Egypt

Drugs / interventions tested

Dermaroller
Topical Vitamin C — full drug profile →

Conditions studied

Acne Vulgaris — all drugs for Acne Vulgaris →
Acne Scars — all drugs for Acne Scars →

Sponsor

Sohag University

Who can join

18 and older, any sex, with Acne Vulgaris or Acne Scars. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the efficacy of dermaroller and topical vitamin C- either separate or combined- in treatment of post acne scars. prospective randomized clinical trial that was The study was a randomized controlled trial, conducted in Sohag Dermatology outpatient clinic between June 2016 and of February 2018. 30 patients with acne scars were included. All patients were informed about the entire procedure, medication, possible side effects and outcomes. A written informed consent was signed from each participant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acne Vulgaris

Currently open trials in the same condition.

NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
NCT07474883 — Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris · EARLY_PHASE1 · recruiting
NCT07186413 — A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne · Phase 3 · recruiting
NCT07056673 — Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study · NA · recruiting
NCT07102186 — Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris · Phase 4 · recruiting

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03522922 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 14 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03522922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing